|
Volumn 24, Issue 6, 2000, Pages 507-509
|
Enhanced ex vivo apoptosis of peripheral granulocytes is a sufficient factor of neutropenia following myeloablative chemotherapy
|
Author keywords
Antineoplastic drugs; Apoptosis; Blood; Granulocytes; Haemopoietic stem cell transplantation
|
Indexed keywords
ACRIDINE ORANGE;
BUSULFAN;
CYCLOPHOSPHAMIDE;
MELPHALAN;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
ACUTE LEUKEMIA;
APOPTOSIS;
ARTICLE;
CHROMATIN CONDENSATION;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DOSE TIME EFFECT RELATION;
GRANULOCYTE;
HODGKIN DISEASE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
NEUTROPENIA;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
ADOLESCENT;
ADULT;
APOPTOSIS;
BREAST NEOPLASMS;
FEMALE;
GRANULOCYTE COLONY-STIMULATING FACTOR;
GRANULOCYTES;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HODGKIN DISEASE;
HUMANS;
LEUKEMIA;
LYMPHOMA, NON-HODGKIN;
MALE;
MIDDLE AGED;
MULTIPLE MYELOMA;
MYELOABLATIVE AGONISTS;
NEUTROPENIA;
TIME FACTORS;
TRANSPLANTATION CONDITIONING;
|
EID: 0033998656
PISSN: 01452126
EISSN: None
Source Type: Journal
DOI: 10.1016/S0145-2126(99)00199-X Document Type: Article |
Times cited : (7)
|
References (8)
|